Genmab As Stock Price History

GMAB Stock  USD 20.51  0.55  2.76%   
Below is the normalized historical share price chart for Genmab AS extending back to June 01, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Genmab AS stands at 20.51, as last reported on the 17th of March 2025, with the highest price reaching 21.07 and the lowest price hitting 20.43 during the day.
IPO Date
1st of June 2009
200 Day MA
23.89
50 Day MA
21.2203
Beta
0.903
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Genmab Stock, it is important to understand the factors that can impact its price. At this point, Genmab AS is very steady. Genmab AS holds Efficiency (Sharpe) Ratio of 0.0281, which attests that the entity had a 0.0281 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Genmab AS, which you can use to evaluate the volatility of the firm. Please check out Genmab AS's Market Risk Adjusted Performance of (0.09), standard deviation of 2.7, and Risk Adjusted Performance of (0.01) to validate if the risk estimate we provide is consistent with the expected return of 0.0774%.
  
At present, Genmab AS's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 48.1 B, whereas Common Stock Total Equity is forecasted to decline to about 52.4 M. . At present, Genmab AS's Price Earnings Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.16, whereas Price To Sales Ratio is forecasted to decline to 4.26. Genmab Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0281

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskGMABHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.75
  actual daily
24
76% of assets are more volatile

Expected Return

 0.08
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Genmab AS is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genmab AS by adding it to a well-diversified portfolio.
Price Book
2.4352
Enterprise Value Ebitda
7.1969
Price Sales
0.607
Shares Float
62.8 M
Wall Street Target Price
31

Genmab AS Stock Price History Chart

There are several ways to analyze Genmab Stock price data. The simplest method is using a basic Genmab candlestick price chart, which shows Genmab AS price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 7, 202524.14
Lowest PriceFebruary 10, 202518.69

Genmab AS March 17, 2025 Stock Price Synopsis

Various analyses of Genmab AS's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Genmab Stock. It can be used to describe the percentage change in the price of Genmab AS from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Genmab Stock.
Genmab AS Price Daily Balance Of Power 0.86 
Genmab AS Price Rate Of Daily Change 1.03 
Genmab AS Price Action Indicator 0.04 

Genmab AS March 17, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Genmab Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Genmab AS intraday prices and daily technical indicators to check the level of noise trading in Genmab Stock and then apply it to test your longer-term investment strategies against Genmab.

Genmab Stock Price History Data

The price series of Genmab AS for the period between Tue, Dec 17, 2024 and Mon, Mar 17, 2025 has a statistical range of 5.45 with a coefficient of variation of 6.11. Under current investment horizon, the daily prices are spread out with arithmetic mean of 21.11. The median price for the last 90 days is 21.0. The company completed 5:1 stock split on 1st of May 2018.
OpenHighLowCloseVolume
03/17/2025
 20.96  21.07  20.43  20.51 
03/14/2025 20.96  21.07  20.43  20.51  953,606 
03/13/2025 19.79  20.26  19.75  19.96  1,397,976 
03/12/2025 20.20  20.36  20.07  20.21  1,813,091 
03/11/2025 20.71  20.83  20.03  20.26  3,925,132 
03/10/2025 23.93  24.05  21.67  21.98  5,894,020 
03/07/2025 24.04  24.33  24.00  24.14  803,338 
03/06/2025 23.76  23.91  23.63  23.71  874,090 
03/05/2025 23.98  24.11  23.86  24.10  604,034 
03/04/2025 23.11  23.46  23.04  23.33  811,685 
03/03/2025 23.25  23.31  22.83  22.96  774,847 
02/28/2025 22.64  22.68  22.43  22.68  1,026,825 
02/27/2025 22.56  22.85  22.55  22.73  920,707 
02/26/2025 22.84  22.93  22.54  22.61  901,994 
02/25/2025 23.13  23.21  22.92  22.96  1,052,817 
02/24/2025 22.46  22.61  22.35  22.50  978,049 
02/21/2025 22.32  22.36  22.07  22.34  1,056,869 
02/20/2025 22.07  22.55  22.07  22.44  1,030,526 
02/19/2025 21.45  22.06  21.45  21.97  1,900,121 
02/18/2025 21.34  21.79  21.30  21.77  1,833,163 
02/14/2025 21.08  21.31  21.01  21.30  2,417,859 
02/13/2025 20.11  20.98  20.03  20.92  1,872,426 
02/12/2025 18.87  19.71  18.74  19.69  1,617,004 
02/11/2025 19.05  19.13  18.87  18.89  1,338,230 
02/10/2025 18.93  19.02  18.64  18.69  950,856 
02/07/2025 19.29  19.36  18.92  19.00  1,245,703 
02/06/2025 19.31  19.47  19.15  19.35  1,866,935 
02/05/2025 19.30  19.63  19.30  19.47  1,788,721 
02/04/2025 19.19  19.43  19.13  19.21  1,147,379 
02/03/2025 19.10  19.37  19.00  19.11  1,291,015 
01/31/2025 19.78  19.97  19.61  19.67  1,321,025 
01/30/2025 19.66  19.85  19.56  19.81  1,281,837 
01/29/2025 19.50  19.86  19.34  19.85  5,369,344 
01/28/2025 19.26  19.59  19.02  19.58  5,384,020 
01/27/2025 21.01  21.42  20.71  20.80  2,448,361 
01/24/2025 21.09  21.31  20.95  21.13  583,220 
01/23/2025 21.26  21.32  21.03  21.29  860,581 
01/22/2025 21.52  21.52  20.96  20.97  926,444 
01/21/2025 21.35  21.85  21.31  21.80  898,955 
01/17/2025 20.85  21.03  20.75  20.80  1,120,114 
01/16/2025 20.93  21.26  20.70  21.22  2,663,042 
01/15/2025 20.39  20.61  19.89  20.23  1,838,334 
01/14/2025 22.00  22.08  21.60  21.64  1,003,220 
01/13/2025 21.64  21.74  21.32  21.72  955,011 
01/10/2025 22.05  22.24  22.00  22.15  895,112 
01/08/2025 22.15  22.21  21.83  22.19  602,971 
01/07/2025 22.19  22.28  22.05  22.18  1,050,789 
01/06/2025 21.48  22.02  21.44  21.86  826,155 
01/03/2025 21.15  21.56  21.12  21.47  839,054 
01/02/2025 21.13  21.20  20.87  21.00  1,021,286 
12/31/2024 20.77  21.14  20.61  20.87  490,651 
12/30/2024 20.82  20.88  20.69  20.77  901,929 
12/27/2024 20.87  21.12  20.81  21.02  950,621 
12/26/2024 20.45  20.61  20.41  20.58  751,943 
12/24/2024 20.65  20.71  20.40  20.47  454,756 
12/23/2024 20.71  20.86  20.50  20.76  1,380,277 
12/20/2024 20.22  20.43  20.13  20.31  1,829,681 
12/19/2024 20.25  20.33  19.99  20.09  1,281,450 
12/18/2024 20.76  21.03  20.12  20.14  1,368,010 
12/17/2024 19.95  20.28  19.90  20.03  1,075,782 
12/16/2024 19.94  20.37  19.85  20.02  2,017,427 

About Genmab AS Stock history

Genmab AS investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genmab is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genmab AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genmab AS stock prices may prove useful in developing a viable investing in Genmab AS
Last ReportedProjected for Next Year
Common Stock Shares Outstanding64.6 M61.4 M
Net Income Applicable To Common Shares6.4 B6.7 B

Genmab AS Quarterly Net Working Capital

22.55 Billion

Genmab AS Stock Technical Analysis

Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genmab AS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genmab AS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Genmab AS Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Genmab AS's price direction in advance. Along with the technical and fundamental analysis of Genmab Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genmab to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Genmab Stock analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency